Drug Information

Product NDC: 43251-2241

Proprietary Name: natralia

Non Proprietary Name: Sodium Borate, Graphite, Potassium Sulfate, and Sodium Chloride

Active Ingredient(s):
  • 20 [hp_X]/g SODIUM BORATE;
  • 6 [hp_X]/g GRAPHITE;
  • 12 [hp_X]/g SODIUM CHLORIDE

Administration Route(s): TOPICAL

Dosage Form(s): CREAM

Labeler Information

Labeler Name: LaCorium Health USA Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Start Marketing Date:3/1/2009
End Marketing Date:9/30/2022

Package Information

No. Package Code Package Description Billing Unit
143251-2241-11 TUBE in 1 CARTON (43251-2241-1) > 56 g in 1 TUBE
243251-2241-21 g in 1 PACKET (43251-2241-2)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43251-2241The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEnatraliaThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIXeczema and psoriasisA suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
NON PROPRIETARY NAMESodium Borate, Graphite, Potassium Sulfate, and Sodium ChlorideThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMECREAMThe translation of the dosage form Code submitted by the firm.
ROUTE NAMETOPICALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE3/1/2009This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE9/30/2022This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMELaCorium Health USA Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMESODIUM BORATE; GRAPHITE; POTASSIUM SULFATE; SODIUM CHLORIDEThis is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
ACTIVE INGRED UNIT[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 7/26/2021